Edward I. Herman

3.7k total citations · 1 hit paper
13 papers, 1.6k citations indexed

About

Edward I. Herman is a scholar working on Immunology, Hematology and Dermatology. According to data from OpenAlex, Edward I. Herman has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Hematology and 3 papers in Dermatology. Recurrent topics in Edward I. Herman's work include T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Edward I. Herman is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Edward I. Herman collaborates with scholars based in United States, Germany and Netherlands. Edward I. Herman's co-authors include Daniel H. Geschwind, Brett S. Abrahams, Elior Peles, Kellen D. Winden, Peyman Golshani, Joel Almajano, Olga Peñagarikano, Hongmei Dong, Lisa I. Sonnenblick and Anatol Bragin and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Blood.

In The Last Decade

Edward I. Herman

12 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits

2011 794 citations Olga Peñagarikano, Brett S. Abrahams et al. Cell profile →

Peers

Countries citing papers authored by Edward I. Herman

Since Specialization

Citations

This map shows the geographic impact of Edward I. Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward I. Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward I. Herman more than expected).

Fields of papers citing papers by Edward I. Herman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward I. Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward I. Herman. The network helps show where Edward I. Herman may publish in the future.

Co-authorship network of co-authors of Edward I. Herman

This figure shows the co-authorship network connecting the top 25 collaborators of Edward I. Herman. A scholar is included among the top collaborators of Edward I. Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward I. Herman. Edward I. Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series. 2025 ·PubMed ·(unknown), Mona Shahriari, Michael C. Cameron, Michael Payette, (unknown), Giovanni Damiani, Edward I. Herman, (unknown), Naiem T. Issa, (unknown), (unknown), Youna Kang, Jeffrey M. Cohen, Christopher G. Bunick	1
2	A retrospective multicenter case series of real-world tralokinumab use in dupilumab-experienced patients 2024 ·JAAD Case Reports ·Edward I. Herman, (unknown), Mona Shahriari	4
3	52244 Early Improvement in Nail and Scalp Psoriasis from a Prospective Observational Study of Patients with Psoriasis in Special Areas (PSoSA) Initiating Ixekizumab: Results from the First Interim Analysis 2024 ·Journal of the American Academy of Dermatology ·Jerry Bagel, (unknown), (unknown), Edward I. Herman, (unknown), Aisha Vadhariya, William N. Malatestinic, Kyoungah See, Baojin Zhu, Joseph F. Merola	2
4	A rare case report for dermatomyofibroma in nasion. 2018 ·PubMed ·Siqi Fu, Jing Zhang, Yi Zhan, Huiming Zhang, Edward I. Herman, Qianjin Lu, Ying Zhou, Guiying Zhang	0
5	STAT4 and T-bet control follicular helper T cell development in viral infections 2017 ·The Journal of Experimental Medicine ·Jason S. Weinstein, Brian J. Laidlaw, Yisi Lu, (unknown), Vincent Schulz, Ningcheng Li, Edward I. Herman, Susan M. Kaech, Patrick G. Gallagher, Joe Craft	90
6	TFH cells progressively differentiate to regulate the germinal center response 2016 ·Nature Immunology ·Jason S. Weinstein, Edward I. Herman, Begoña Lainez, Paula Licona-Limón, Enric Esplugues, Richard A. Flavell, Joe Craft	282
7	Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR 2014 ·Molecular Psychiatry ·Asami Oguro‐Ando, Clark Rosensweig, Edward I. Herman, Yuhei Nishimura, Donna M. Werling, Brent Bill, (unknown), Fuying Gao, Giovanni Coppola, Brett S. Abrahams, Daniel H. Geschwind	88
8	Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits breakdown → 2011 ·Cell ·Olga Peñagarikano, Brett S. Abrahams, Edward I. Herman, Kellen D. Winden, Amos Gdalyahu, Hongmei Dong, Lisa I. Sonnenblick, (unknown), Joel Almajano, Anatol Bragin, Peyman Golshani, Joshua T. Trachtenberg, Elior Peles, Daniel H. Geschwind	794
9	Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo 2008 ·The Journal of Immunology ·Pia Björck, Andreas Beilhack, Edward I. Herman, Robert S. Negrin, Edgar G. Engleman	24
10	Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs 2007 ·Blood ·Andreas Beilhack, Stephan Schulz, Jeanette Baker, Georg F. Beilhack, Ryosei Nishimura, Enosh M. Baker, Gilad Landan, Edward I. Herman, Eugene C. Butcher, Christopher H. Contag, Robert S. Negrin	87
11	Prevention of acute graft-versus-host disease despite compensatory function of lymphoid organs in vivo 2006 ·Biology of Blood and Marrow Transplantation ·Andreas Beilhack, Stephan Schulz, Jeanette Baker, Georg F. Beilhack, Ryosei Nishimura, Gilad Landan, Enosh M. Baker, Edward I. Herman, E C Butcher, Christopher H. Contag, Robert S. Negrin	1
12	In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets 2005 ·Blood ·Andreas Beilhack, Stephan Schulz, Jeanette Baker, Georg F. Beilhack, (unknown), Edward I. Herman, Enosh M. Baker, Yuan Cao, Christopher H. Contag, Robert S. Negrin	259
13	Prevention of Acute Graft-Versus-Host Disease Despite Compensatory Function of Lymphoid Organs In Vivo. 2005 ·Blood ·Andreas Beilhack, Stephan Schulz, Jeanette Baker, Georg F. Beilhack, Ryosei Nishimura, Gilad Landan, Enosh M. Baker, Edward I. Herman, Eugene C. Butcher, Christopher H. Contag, Robert S. Negrin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact